Skip to main content
Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
4.840
+1.310 (37.11%)
At close: Dec 20, 2024, 4:00 PM
4.870
+0.030 (0.62%)
After-hours: Dec 20, 2024, 7:11 PM EST

Elutia Revenue

Elutia had revenue of $5.92M in the quarter ending September 30, 2024, a decrease of -3.35%. This brings the company's revenue in the last twelve months to $24.78M, down -2.65% year-over-year. In the year 2023, Elutia had annual revenue of $24.75M with 3.76% growth.

Revenue (ttm)
$24.78M
Revenue Growth
-2.65%
P/S Ratio
5.11
Revenue / Employee
$458,926
Employees
54
Market Cap
167.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.75M896.00K3.76%
Dec 31, 202223.85M-23.54M-49.68%
Dec 31, 202147.39M4.71M11.03%
Dec 31, 202042.68M-219.00K-0.51%
Dec 31, 201942.90M3.86M9.90%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.04M
Akoya Biosciences 86.82M
Enanta Pharmaceuticals 67.64M
Protalix BioTherapeutics 45.67M
Lineage Cell Therapeutics 8.72M
Revenue Rankings

ELUT News

More News